Accessibility Tools

Skip to main content

Oncology Acupuncture 102: Advanced Clinical Decision-Making, Safety Governance, and System Integration

Description/overview:

Oncology Acupuncture 102 is a 4-hour advanced pre-conference workshop designed for clinicians with prior oncology acupuncture exposure who seek deeper training in clinical judgment, safety governance, and system integration. Building on the success of Oncology Acupuncture 101 at SIO 2025, this workshop responds to strong demand for longer, more clinically applied, case-based education. As acupuncture and acupressure services expand across cancer centers, many programs now operate across multiple sites with variable oncology-specific training and limited formal governance. In these settings, risk is often driven less by needling technique and more by errors in clinical judgment, including misinterpretation of oncology data, unclear scope of practice, delayed escalation, and weak integration with oncology workflows. This workshop addresses that advanced gap through four integrated modules: interpretation of high-impact oncology signals, facilitated case-based clinical decision-making, ESAS-informed planning and outcome logic, and translation of oncology constraints into bounded acupuncture strategies. Faculty-guided small-group discussions will focus on real-world oncology scenarios involving laboratory trends, imaging impressions, active therapies, symptom burden, scope boundaries, and escalation pathways. Participants will receive an Oncology Acupuncture 102 Handbook, case worksheets, structured decision frameworks, and documentation templates aligned with oncology standards. A certificate of completion will be provided, and CE credits will be offered in accordance with SIO and relevant accrediting body requirements.

Learning Objectives:

  1. Interpret key oncology data streams, including laboratory values, imaging summaries, active therapies, and symptom burden, as inputs for acupuncture decision-making.
  2. Apply structured risk stratification and governance frameworks to determine when acupuncture may proceed, require modification, be deferred, or require oncology escalation.
  3. Demonstrate defensible case-based clinical reasoning in complex oncology scenarios involving metastatic disease, cytopenias, treatment toxicities, and survivorship contexts.
  4. Translate oncology constraints into bounded acupuncture strategies and appropriate documentation, referral, and stop-rule plans consistent with institutional accountability.
  5. Integrate ESAS and other symptom measures into triage, treatment prioritization, and outcome-based monitoring of acupuncture effectiveness over time.

Target Audience:

Oncology-trained acupuncturists, integrative oncology clinicians, and oncology providers involved in supportive care oversight or referral pathways. Participants are expected to have prior oncology acupuncture exposure or equivalent clinical experience. This is an advanced workshop focused on clinical decision-making, governance, and system integration rather than introductory safety or protocol teaching.

Prerequisites:

This workshop is not introductory. Participants are expected to have completed Oncology Acupuncture 101 or demonstrate equivalent oncology acupuncture training or clinical experience. Attendees will self-attest to prior oncology exposure during registration to ensure appropriate readiness. For those who have not attended Oncology Acupuncture 101, the digital handbook and recorded instructional materials from the 101 workshop will be made available in advance to support foundational preparation.

Facilitators:

Weidong Lu, MB, MPH, PhD

Weidong Lu, MB, MPH, PhD, is a leader in integrative oncology and oncology acupuncture at Dana-Farber Cancer Institute, where he serves as team leader and principal investigator at the Dana-Farber/Harvard Cancer Center. He leads the Chinese Medicine Initiative and has played a central role in developing oncology acupuncture as a clinical subspecialty within cancer care. He is an Instructor at Harvard Medical School, Professor Emeritus at the New England School of Acupuncture, and Chair of the Acupuncture Committee of the Massachusetts Board of Registration in Medicine. A long-standing member and former board member of the Society for Integrative Oncology, he has authored over 60 peer-reviewed publications.

Ting Bao, MD, MS, FSIO

Ting Bao, MD, MS, FSIO, is a breast medical oncologist and integrative oncology leader. She serves as Co-Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living at Dana-Farber Cancer Institute and is an Associate Professor at Harvard Medical School. A past President of the Society for Integrative Oncology (SIO), she currently co-chairs its Research Committee and previously co-chaired its Education Committee. Dr. Bao is a medical acupuncturist and integrative medicine physician whose research focuses on clinical trials of acupuncture and mind–body interventions to improve symptom control and quality of life in cancer care.

Susan Veleber, DACM, MS, LAc

Susan Veleber, DACM, MS, LAc, is Acupuncture Supervisor in the Integrative Medicine Program at Fred Hutchinson Cancer Center and a Research Associate with the Greenlee Lab. She has practiced at Cleveland Clinic and Mayo Clinic and has advanced training in oncology acupuncture. Her work focuses on delivering evidence-based acupuncture within multidisciplinary cancer care, with an emphasis on safety, symptom management, and survivorship. Her research examines the safe integration of acupuncture during active treatment and across the cancer continuum. Dr. Veleber serves on the Board of Trustees of the Society for Integrative Oncology and is Co-Chair of the SIO Acupuncture Special Interest Group.

W. Iris Zhi, MD, PhD

Iris Zhi, MD, PhD, is a breast medical oncologist and integrative oncology specialist at NYU Langone Perlmutter Cancer Center–Long Island, where she serves as Associate Professor and Medical Director of Clinical Operations in Medical Oncology. Her research focuses on breast cancer in older adults and integrative approaches, including acupuncture for chemotherapy-induced peripheral neuropathy. A recipient of the Society for Integrative Oncology Young Investigator Award and a Gateway Foundation grant, she has contributed to the evidence base in integrative oncology. Dr. Zhi serves on the SIO Board of Trustees and is active in research, mentorship, and program development.

Suzanna M. Zick, ND, MPH

Dr. Zick is a Research Professor in Family Medicine and Nutritional Sciences and Co-Director of the Integrative Family Medicine Program at the University of Michigan. Her research focuses on the implementation and effectiveness of integrative therapies, including self-acupressure and dietary interventions, to manage cancer-related fatigue, sleep disturbance, and quality of life. She has developed a mobile application to support delivery of self-acupressure in clinical and community settings. Dr. Zick directs an NCI-funded education program in integrative oncology and contributes to national training efforts through the Society for Integrative Oncology. She co-directs the SIO Clinical Practice Guideline Committee and served on the 2024 ASCO–SIO fatigue guideline panel.

Eleanor M. Walker, MD

Eleanor M. Walker, MD, is a radiation oncologist and integrative oncology leader at Henry Ford Health, where she serves as a senior physician at Henry Ford Cancer and Division Director of Breast Services in Radiation Oncology. Her clinical and research interests include breast and prostate cancer, radiosurgery, cancer disparities, and integrative therapies. She was first author of a Journal of Clinical Oncology randomized trial evaluating acupuncture for vasomotor symptoms in breast cancer. Nationally active in the Society for Integrative Oncology, she is co-chair of the SIO 2026 International Conference. Dr. Walker brings clinical and organizational leadership to integrative cancer care.

Zeyiad Elias, DAOM, LAc

Zeyiad Elias, DAOM, LAc, is a board-certified acupuncturist and herbalist at Henry Ford Health, where he provides acupuncture within an integrative oncology setting. He completed his master’s training at Pacific College of Health and Science and his doctorate at Bastyr University, with a focus on oncology care. His clinical work centers on symptom management and supportive care for patients undergoing cancer treatment and survivorship. He has completed oncology-focused training in China at Sichuan Cancer Hospital of Integrated Chinese and Western Medicine and Shanghai University of Traditional Chinese Medicine. He also holds an academic appointment at Michigan State University College of Human Medicine.

Ryan Gauthier, DAOM, LAc, LMT

Ryan Gauthier, DAOM, LAc, LMT, is an acupuncturist at Henry Ford Health Center for Integrative Medicine and serves as Manager of Integrative and Functional Medicine. He completed his doctoral training in acupuncture and Chinese medicine at Oregon College of Oriental Medicine and holds additional training in integrative healthcare leadership. Dr. Gauthier is a Certified Oncology Acupuncturist and provides acupuncture as part of a multidisciplinary care model. His clinical work focuses on symptom management, pain, and whole-person care, integrating acupuncture with nutrition, bodywork, and lifestyle approaches. He brings both clinical and operational leadership experience in delivering integrative medicine services within a large health system.